Brief: Rockwell Medical Submits Supplemental Data To FDA For IND Application For Phase 2 FPC Home Infusion Trial

Rockwell Medical

12/05/2022 13:11

May 12 (Reuters) - Rockwell Medical Inc  RMTI.O :
    * ROCKWELL MEDICAL SUBMITS SUPPLEMENTAL DATA TO FDA FOR IND
APPLICATION FOR PHASE 2 FPC HOME INFUSION TRIAL
    * ROCKWELL MEDICAL - ADDITIONAL DATA RELATE TO PHYSICAL,
CHEMICAL,
MICROBIOLOGICAL STABILITY OF FPC IN SUPPORT OF SUGGESTED METHOD
OF ADMINISTRATION
    * ROCKWELL MEDICAL - IF FDA HAS NO FURTHER
QUESTIONS/REQUIREMENTS
RELATED TO SUBMISSION, WOULD EXPECT TRIAL TO START SHORTLY AFTER
REVIEW PERIOD ENDS

Source text for Eikon:  ID:nPn9Ylvkza 
Further company coverage:  RMTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))